PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.4642
-0.0258 (-5.27%)
At close: Aug 6, 2025, 4:00 PM
0.4642
0.00 (0.00%)
Pre-market: Aug 7, 2025, 5:42 AM EDT
Accolade Market Cap
PAVmed has a market cap or net worth of $8.18 million as of August 7, 2025. Its market cap has decreased by -13.91% in one year.
Market Cap
8.18M
Enterprise Value
14.37M
1-Year Change
-13.91%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $8.18M, a decrease of -95.27%. That is a compound annual growth rate of -28.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 8.60M | 24.64% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
| Jul 28, 2016 | 173.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.30B |
| Johnson & Johnson | 412.64B |
| AbbVie | 345.33B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| Abbott Laboratories | 228.24B |
| UnitedHealth Group | 224.39B |
| Novo Nordisk | 210.71B |